Drug Device Combination Products Market Share, Trends, Growth, Opportunities and Forecast 2027

According to the latest report by IMARC Group, titled "Drug Device Combination Products Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global drug device combination products market reached a value of US$ 132.45 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 214.53 Billion by 2027, exhibiting at a CAGR of 8.27% during 2022-2027.

competitive landscape.

Report Metric

Historical: 2016-2021

Base Year: 2021

Forecast Year: 2022-2027

Download free sample of the report: https://www.imarcgroup.com/drug-device-combination-products-market/requestsample

Drug Device Combination Products Market Industry Definition and Application:

Drug device combination products include medical devices and pharmaceutical ingredients that help deliver the drug to a preferred location in the patient's body. They comprise drug-eluting stents, infusion pumps, inhalers, transdermal delivery systems, and prefilled syringes. They have minimal side effects and offer advantages like controlled drug administration and improved patient compliance.

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Drug Device Combination Products Market Trends and Drivers:

The growing prevalence of chronic diseases, such as asthma, cancer, diabetes, and cardiovascular disorders, represents one of the key factors driving the market. Moreover, rising preferences for smart and precision drug delivery systems, which minimize the amount of drug required for therapeutic efficacy, are driving the demand for drug device combination products across the globe. Besides this, several market players are introducing advanced technologies for tracking and monitoring different products. They are also expending on extensive research and development (R&D) activities to develop next-generation products with high viscosity and formulations. Furthermore, the growing popularity of minimally invasive surgery (MIS) and portable devices like nebulizers and inhalers are other growth-inducing factors positively influencing the market.

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/drug-device-combination-products-market

Drug Device Combination Products Market Segmentation:

The report has segmented the market on the basis on region, product, application, end user.

Breakup by Product:

Drug Eluting Stents
Transdermal Patches
Infusion Pumps
Drug Eluting Balloon
Inhalers
Others

Breakup by Application:

Cardiovascular
Diabetes
Cancer Treatment
Respiratory Diseases
Others

Breakup by End User:

Hospitals
Ambulatory Surgical Centers
Others

Breakup by Region:

North America: (United States, Canada)
Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico, Others)
Middle East and Africa

Who are the Major Drug Device Combination Products Market Key players?

Abbott Laboratories, Baxter International Inc., Bayer AG, Becton Dickinson and Company, Boston Scientific Corporation, GlaxoSmithKline plc, Johnson & Johnson, Medtronic plc, Novartis AG, Smith & Nephew plc, Stryker Corporation and Terumo Corporation.

Related Reports by IMARC Group:

Europe Organ Preservation Market Report: https://www.imarcgroup.com/europe-organ-preservation-market

Latin America Generic Injectables Market Report: https://www.imarcgroup.com/latin-america-generic-injectables-market

Drug Abuse Testing Market Report: https://www.imarcgroup.com/drug-abuse-testing-market

Protein Purification and Isolation Market Report: https://www.imarcgroup.com/protein-purification-isolation-market

Recombinant DNA Technology Market Report: https://www.imarcgroup.com/recombinant-dna-technology-market

United States Insulin Pumps Market Report: https://www.imarcgroup.com/united-states-insulin-pumps-market

Biosurgery Market Report: https://www.imarcgroup.com/biosurgery-market

Pen Needles Market Report: https://www.imarcgroup.com/pen-needles-market

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.